Gosset SOPHiA GENETICS General Information
SOPHiA GENETICS has developed a cloud-based AI-driven SaaS platform—SOPHiA DDM™—that analyzes complex multimodal health data to generate actionable insights for clinicians and researchers. Their technology supports over two million genomic profiles analyzed across more than 770 institutions worldwide. Products are available for research use globally, with some CE-IVD marked solutions for clinical diagnostics in Europe. The company’s impact includes improved precision oncology workflows and rare disease diagnosis support. No direct clinical trial results are reported as the company does not develop therapeutics but enables better patient outcomes through advanced analytics.
Contact Information
Switzerland
Drug Pipeline
No pipeline data available
Key Partnerships
Over 770 healthcare institutions worldwide, BioPharma partnerships for AI-powered drug discovery/development support
SOPHiA GENETICS Funding
No funding data available